Mortality Risk Higher for Transgender Individuals Taking Hormones
There is a substantial and persistent increased mortality risk among transgender people using hormone treatment, regardless of treatment type.
Hormone Replacement Therapy
Cutaneous Melanoma Risk and Menopausal Hormone Therapy
Associations between estrogen therapy, estrogen-progestin therapy, and cutaneous melanoma risk were estimated.
Current Use of Hormonal Contraceptives May Up Glaucoma Risk
Women of reproductive age who currently use hormonal contraceptives are at higher risk for developing glaucoma.
Diagnosis, Treatment of Gender Dysphoria Varies Among Children
Only 29% of children and adolescents with gender dysphoria receive a gender dysphoria-related diagnosis, and 25% are prescribed gender-affirming hormonal treatment.
Gender-Affirming Surgery Boosts Mental Health in Transgender Adults
The researchers studied links between gender-affirming surgeries and mental health outcomes, including psychological distress, substance use, and suicide risk.
Decrease in HDL Observed Among Transgender Male Patients Receiving Gender-Affirming Hormone Therapy
A team of researchers assessed laboratory parameters in patients undergoing gender-affirming hormone therapy.
Gender-Affirming Hormone Therapy Tied to Systolic BP Changes
Within two to four months of starting gender-affirming hormone therapy,, transfeminine adults have lower mean systolic blood pressure and transmasculine adults have higher mean systolic blood pressure.
Addressing Pulmonary Care Among Transgender Patients: Improvement, Research Needed
Higher rates of smoking, lower rates of lung cancer screening, and more diagnoses of asthma and COPD have been seen in transgender vs cisgender individuals.
Women Who Undergo Surgery to Remove Fallopian Tubes and Ovaries Can Experience Declines in Cognitive Function
Risk-reducing bilateral salpingo-oophorectomy can reduce the risk of ovarian cancer for BRCA1 and BRCA2 carriers, but the surgery leads to early menopause. Little is known how undergoing the surgery will affect cognition in women who undergo the procedure. In this featured study, researchers share new findings.
Pilot Clinical Trial Shows Benefits of Hormone Therapy for Nocturia in Postmenopausal Women
Excessive urination at night, or nocturia, is not uncommon in postmenopausal women. There are a number of treatment options available but with varying degrees of success.
- Loading...
Loading...
Next post in Androgen and Reproductive Disorders
Loading... 
Loading...